International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 120

Research Paper | Medicine Science | Volume 7 Issue 1, January 2018 | Pages: 1038 - 1042 | Russia


Development of Polycystic Ovary Syndrome in Patient with a Classic Variant of Congenital Adrenal Dysfunction

L. A. Ivanova, I. V. Korol, Yu. S. Kovalenko, L. N. Malkhasyan, K. A. Avdzhyan

Abstract: A retrospective analysis of the viril (simple) form of congenital adrenal dysfunction (CAD) was performed against the backdrop of alternating periods of compensation and decompensation of the disease. During the observation period a number of laboratory and instrumental methods of investigation were performed and evaluated. The importance of hormone replacement therapy for all stages of ontogenesis is shown to prevent the development of complications.

Keywords: congenital adrenal dysfunction, polycystic ovary syndrome

How to Cite?: L. A. Ivanova, I. V. Korol, Yu. S. Kovalenko, L. N. Malkhasyan, K. A. Avdzhyan, "Development of Polycystic Ovary Syndrome in Patient with a Classic Variant of Congenital Adrenal Dysfunction", Volume 7 Issue 1, January 2018, International Journal of Science and Research (IJSR), Pages: 1038-1042, https://www.ijsr.net/getabstract.php?paperid=ART20178942, DOI: https://dx.doi.org/10.21275/ART20178942

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.